corifact (factor xiii concentrate- human kit
csl behring gmbh - factor xiii concentrate (human) (unii: f7r0fbc1xd) (factor xiii concentrate (human) - unii:f7r0fbc1xd) - factor xiii concentrate (human) 1600 [iu] in 20 ml - corifact is a factor xiii concentrate indicated for routine prophylactic treatment and peri-operative management of surgical bleeding in adult and pediatric patients with congenital fxiii deficiency. corifact is contraindicated in patients with known anaphylactic or severe systemic reactions to human plasma-derived products [see description (11)] . risk summary animal reproduction studies have not been conducted with corifact. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations: disease-associated maternal and/or embryo/fetal risk miscarriage is a known complication of congenital fxiii deficiency with a rate of 91% observed in 136 pregnancies without routine fxiii supplementation prophylaxis and 11% in 45 pregnancies with routine fxiii prophylaxis1 . risk summary there is no information available on the presence of corifact in human milk, the effects on the breastfed
profilnine- factor ix complex kit
grifols usa, llc - factor ix complex (unii: fw411qxd5m) (factor ix complex - unii:fw411qxd5m) - factor ix complex 500 [iu] in 5 ml - profilnine, factor ix complex, is indicated for the prevention and control of bleeding in patients with factor ix deficiency (hemophilia b). profilnine contains non-therapeutic levels of factor vii and is not indicated for use in the treatment of factor vii deficiency. none known.
optivate 250iu powder and solvent for solution for injection, human coagulation factor viii
bpl bioproducts laboratory gmbh dornhofstraße 34, 63263 neu-isenburg,, germany - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 250 iu von willebrand factor, human 430 iu - antihemorrhagics
optivate 500iu powder and solvent for solution for injection, human coagulation factor viii
bpl bioproducts laboratory gmbh dornhofstraße 34, 63263 neu-isenburg,, germany - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 500 iu von willebrand factor, human 860 iu - antihemorrhagics
optivate 1000iu powder and solvent for solution for injection, human coagulation factor viii
bpl bioproducts laboratory gmbh dornhofstraße 34, 63263 neu-isenburg,, germany - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 1000 iu von willebrand factor, human 1720 iu - antihemorrhagics
haemate p 1000 iu fviii 2400 iu vwf
csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 1000 iu / 15 ml; von willebrand factor 2400 iu / 15 ml - coagulation factor viii - coagulation factor viii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia,prophylaxis during operation, von willebrands disease.
haemate p 250 iu fviii 600 iu vwf
csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 250 iu / 5 ml; von willebrand factor 600 iu / 5 ml - coagulation factor viii - coagulation factor viii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrand's disease.
haemate p 500 iu fviii 1200 iu vwf
csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 500 iu / 10 ml; von willebrand factor 1200 iu / 10 ml - coagulation factor xiii - coagulation factor xiii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrands disease.
biostate human coagulation factor viii 500iu/ von willebrand factor 1200iu powder for injection vial with diluent vial
csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
factor vii takeda 600 ui/vial polvo liofilizado para solución inyectable + solvente i.v.
takeda manufacturing austria ag - factor vii - factor vii....600 ui / agua inyectable....10 ml